Wealth Management

Healthcare stocks have sharply outperformed the broader market over the past month, with the S&P 500 Healthcare Sector up more than 6%, far outpacing the S&P 500’s modest gain. A key driver has been exceptional strength in major pharmaceutical names, including strong earnings from Eli Lilly and big tariff exemption deals struck by Lilly, Novo Nordisk, and Pfizer with the Trump administration.

 

These catalysts, along with record-breaking sales of GLP-1 drugs like tirzepatide, have pushed heavyweight pharma stocks sharply higher, giving an outsized lift to the market-cap-weighted sector index.

 

With pharma leadership, defensive momentum, and recent outperformance, analysts suggest this may be a compelling moment for investors to consider adding exposure to the healthcare sector.


Finsum: Investors are also rotating into defensive sectors, such as healthcare, consumer staples, and energy, as concerns about market overvaluation and an AI-driven bubble grow.

Private credit firms are increasingly shifting from traditional cash-flow lending toward asset-backed finance using collateral that now includes intellectual property, data centers, and energy infrastructure. 

 

Despite the US ABF market totaling $5.5 trillion, private credit holds only a small share and is partnering more frequently with banks to expand. The recent bankruptcy of First Brands has raised concerns about how well lenders understand the risks in ABF, especially as more unfamiliar assets require precise valuation in a downturn. 

 

Demand for digital and energy infrastructure is driving ABF growth, with data center financing alone expected to jump sharply by 2028. Yet the sector has not been tested under high interest rates or recessionary conditions, prompting warnings from regulators about potential systemic risks. 


Finsum: Look for asset return correlation in stress scenario to test your demand for private markets.

The S&P 500 fell last week, marking its weakest performance since early October as investors sold off tech stocks amid fading hopes for a December rate cut. Market volatility jumped sharply, with the CBOE Volatility Index rising roughly 14 percent and signaling heightened investor anxiety. 

 

Expectations for a rate cut dropped meaningfully, and concerns around inflated AI valuations added further pressure to the tech-driven market. 

 

In this environment, some investors are turning to volatility ETFs as tactical tools to hedge near-term uncertainty and potentially benefit from market swings. Several ETFs, including VXX, VIXY, and VIXM, offer exposure to VIX futures for those seeking short-term protection or volatility-linked opportunities.


Finsum: Rapid capital inflows into AI resemble past speculative bubbles, increasing the risk of concentrated losses if sentiment shifts.

Page 4 of 379

Contact Us

Newsletter

Subscribe

Subscribe to our daily newsletter

Top